Monday, January 9, 2017

UPDATE 3-Japan's Takeda to buy U.S. cancer drug maker Ariad in $5.2 bln deal

Jan 9 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd

said it would buy cancer drug maker Ariad

Pharmaceuticals Inc in a deal valued at $5.20 billion,

to beef up its oncology pipeline.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)